Table of Content

1 INTRODUCTION 
    1.1 OBJECTIVES OF THE STUDY  
    1.2 MARKET DEFINITION  
           1.2.1 KEY INCLUSIONS & EXCLUSIONS 
    1.3 RESEARCH SCOPE  
           1.3.1 MARKETS COVERED 
           1.3.2 MARKET SCOPE 
           1.3.3 YEARS CONSIDERED FOR THE STUDY 
    1.4 CURRENCY USED FOR THE STUDY 
    1.5 STAKEHOLDERS  
    1.6 SUMMARY OF CHANGES   
           1.6.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY  
    2.1 RESEARCH DATA SOURCES 
           2.1.1 SECONDARY RESEARCH
           2.1.2 PRIMARY RESEARCH
                    2.1.2.1 PRIMARY SOURCES
                    2.1.2.2 KEY INDUSTRY INSIGHTS
                    2.1.2.3 BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE AND MARKET SHARE ESTIMATION METHODOLOGY 
           2.2.1 REVENUE-MAPPING BASED MARKET ESTIMATION
           2.2.2 PROCEDURE BASED MARKET ESTIMATION
           2.2.3 PRIMARY RESEARCH VALIDATION
    2.3 MARKET  BREAKDOWN AND DATA TRIANGULATION 
    2.4 RECESSION IMPACT ASSESMENT APPROACH 
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS 
           2.6.1 SCOPE RELATED LIMITATIONS
           2.6.2 METHODOLOGY RELATED LIMITATIONS
    2.7 RISK ASSESSMENT 
3 EXECUTIVE SUMMARY  
4 PREMIUM INSIGHTS  
5 MARKET OVERVIEW  
    5.1 MARKET DYNAMICS  
           5.1.1 MAJOR DRIVERS 
           5.1.2 KEY RESTRAINTS
           5.1.3 KEY GROWTH OPPORTUNITIES 
           5.1.4 INDUSTRY-SPECIFIC CHALLENGES 
    5.2 REGULATORY LANDSCAPE 
           5.2.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
           5.2.2 REGULATORY TRENDS
    5.3 VALUE CHAIN ANALYSIS 
    5.4 SUPPLY CHAIN ANALYSIS 
    5.5 ECOSYSTEM COVERAGE 
    5.6 PORTER’S FIVE FORCE ANALYSIS 
    5.7 TRADE DATA ANALYSIS 
    5.8 PRICING ANALYSIS  
           5.8.1 AVERAGE SELLING PRICE TREND, BY REGION
           5.8.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
    5.9 TECHNOLOGY ANALYSIS 
    5.10 PATENT ANALYSIS 
    5.11 KEY CONFERENCES AND EVENTS IN 2023-24 
    5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.12.1 KEY STAKEHOLDERS AND BUYING CRITERIA
           5.12.2 BUYING CRITERIA
6 ANALYTICAL STANDARDS MARKET, BY TECHNIQUE (USD MILLION; 2021—2028)*  
    6.1 INTRODUCTION 
    6.2 CHROMATOGRAPHY 
           6.2.1 ION CHROMATOGRAPHY
           6.2.2 GAS CHROMATOGRAPHY
           6.2.3 LIQUID CHROMATOGRAPHY
           6.2.4 THIN CHROMATOGRAPHY
           6.2.5 OTHER CHROMATOGRAPHY
    6.3 SPECTROSCOPY 
           6.3.1 ATOMIC ABSORPTION SPECTROSCOPY
           6.3.2 MASS SPECTROSCOPY 
           6.3.3 IR SPECTROSCOPY 
           6.3.4 NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
           6.3.5 X-RAY FLUORESCENCE/DIFFRACTION SPECTROSCOPY
           6.3.6 UV/VIS SPECTROSCOPY
           6.3.7 OTHER SPECTROSCOPY
    6.4 TITRIMETRY 
    6.5 PHYSICAL PROPERTY TESTING 
           6.5.1 VISCOSITY TESTING
           6.5.2 SIEVE CALIBRATION & PARTICLE SIZE TESTING 
           6.5.3 COLOR REFERENCE TESTING 
           6.5.4 OTHERS
7 ANALYTICAL STANDARDS MARKET, BY APPLICATION (USD MILLION; 2021—2028)*  
    7.1 INTRODUCTION 
    7.2 FOOD & BEVERAGES STANDARDS 
           7.2.1 FLAVOR & FRAGNANCE STANDARDS 
           7.2.2 CARBOHYDRATE STANDARDS 
           7.2.3 PEPTIDE/AMINO ACID STANDARDS
           7.2.4 FOOD ADDITIVE STANDARDS
           7.2.5 FATTY ACID/LIPID/FAME STANDARDS 
           7.2.6 GMO (GENETICALLY MODIFIED ORGANISMS) STANDARDS 
           7.2.7 MYCOTOXINS STANDARDS
    7.3 FORENSIC STANDARDS 
           7.3.1 DRUG OF ABUSE STANDARDS 
           7.3.2 DOPING STANDARDS 
    7.4 VETERINARY DRUG STANDARDS 
           7.4.1 ANTIBIOTIC STANDARDS 
           7.4.2 HORMONE STANDARDS 
    7.5 ENVIRONMENTAL STANDARDS 
           7.5.1 PESTICIDE STANDARDS 
           7.5.2 VOLATILES/SEMIVOLATILES STANDARDS 
           7.5.3 FLAME RETARDANT STANDARDS
           7.5.4 AROCLOR/PCB, AND DIOXIN STANDARDS 
           7.5.5 ALKYL PHENOL STANDARDS
           7.5.6 SOLID WASTE STANDARDS 
    7.6 PETROCHEMISTRY STANDARDS 
           7.6.1 GASOLINE, DIESEL, AND PETROLEUM STANDARDS 
           7.6.2 BIOFUEL STANDARDS 
    7.7 PHARMACEUTICAL AND LIFE SCIENCE STANDARDS 
           7.7.1 COSMETIC STANDARDS 
           7.7.2 HERBAL DRUG/PHYTOPHARMACEUTICAL STANDARDS 
           7.7.3 PHARMACEUTICAL SECONDARY STANDARDS
           7.7.4 PHARMACEUTICAL IMPURITY REFERENCE STANDARDS 
           7.7.5 PHARMACOPOEIA STANDARDS 
           7.7.6 FLUORESCENT MICROPARTICLE STANDARDS
8 ANALYTICAL STANDARDS MARKET, BY METHODOLOGY (USD MILLION; 2021—2028)*  
    8.1 INTRODUCTION 
    8.2 BIOANALYTICAL TESTING 
    8.3 STABILITY TESTING 
    8.4 RAW MATERIAL TESTING 
    8.5 DISSOLUTION TESTING 
    8.6 OTHER METHODLOGIES  
9 ANALYTICAL STANDARDS MARKET, BY CATEGORY (USD MILLION; 2021—2028)*  
    9.1 INTRODUCTION 
    9.2 ORGANIC ANALYTICAL STANDARDS 
    9.3 INORGANIC ANALYTICAL STANDARDS 
10 ANALYTICAL STANDARDS MARKET, BY REGION (USD MILLION; 2021—2028)*  
     10.1 NORTH AMERICA 
             10.1.1 RECESSION IMPACT
             10.1.2 US
             10.1.3 CANADA 
     10.2 EUROPE  
             10.2.1 RECESSION IMPACT
             10.2.2 GERMANY
             10.2.3 UK
             10.2.4 FRANCE
             10.2.5 ITALY 
             10.2.6 SPAIN 
             10.2.7 REST OF EUROPE (ROE)
     10.3 ASIA-PACIFIC 
             10.3.1 RECESSION IMPACT
             10.3.2 JAPAN 
             10.3.3 CHINA 
             10.3.4 INDIA 
             10.3.5 SOUTH KOREA 
             10.3.6 AUSTRALIA 
             10.3.7 REST OF ASIA-PACIFIC (ROAPAC)
     10.4 LATIN AMERICA 
             10.4.1 RECESSION IMPACT
             10.4.2 BRAZIL
             10.4.3 MEXICO
             10.4.4 REST OF LATIN AMERICA (ROLA)
     10.5 MIDDLE EAST AND AFRICA  
             10.5.1 RECESSION IMPACT
11  COMPETITIVE LANDSCAPE  
     11.1 OVERVIEW  
     11.2 REVENUE ANALYSIS OF KEY PLAYERS (2022)  
     11.3 MARKET SHARE ANALYSIS (IN TERMS OF % REVENUE, IN 2022)  
     11.4 KEY PLAYER STRATEGIES/RIGHT TO WIN (2021-2023)  
     11.5 COMPETITIVE SCENARIO AND TRENDS (2021-2023)  
             11.5.1 PRODUCT LAUNCHES AND APPROVALS
             11.5.2 DEALS
     11.6 COMPANY EVALUATION MATRIX  
             11.6.1 STARS
             11.6.2 EMERGING LEADERS
             11.6.3 PERVASIVE PLAYERS
             11.6.4 PARTICIPANTS
             11.6.5 COMPANY FOOTPRINT
     11.7 START-UP/SME EVALUATION MATRIX  
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 RESPONSIVE COMPANIES
             11.7.3 DYNAMIC COMPANIES
             11.7.4 STARTING BLOCKS
             11.7.5 COMPETITIVE BENCHMARKING
12 COMPANY PROFILES** 
(Business Overview, Products Offered, Industry-specific Developments for 2021-2023)***
     12.1 KEY COMPANIES  
             12.1.1 MERCK KGAA
             12.1.2 AGLIENT TECHNOLOGIES 
             12.1.3 WATERS CORPORATION
             12.1.4 LGC STANDARDS
             12.1.5 PERKINELMER, INC.
             12.1.6 RESTEK CORPORATION
             12.1.7 SPEX CERTICEP
             12.1.8 ACCUSTANDARDS, INC.
             12.1.9 THERMO FISHER SCIENTIFIC, INC.
             12.1.10 THE UNITED STATES PHARMACOPEIAL CONVENTION (USP)
             12.1.11 MALLINCKRODT
             12.1.12 CAYMAN CHEMICAL COMPANY
             12.1.13 RICCA CHEMICAL COMPANY
             12.1.14 GFS CHEMICALS, INC.
             12.1.15 CHIRON AS
     12.2 OTHER PLAYERS  
             12.2.1 CAMBRIDGE ISOTOPE LABORATORIES
             12.2.2 REAGECON DIAGNSOTICS LTD
             12.2.3 CPI INTERNATIONAL
             12.2.4 CRESCENT CHEMICAL
             12.2.5 INORGANIC VENTURES
             12.2.6 BIOSYNTH 
             12.2.7 HPC STANDARDS GMBH
             12.2.8 TCI CHEMICALS
             12.2.9 SIMSON PHARMA LIMITED 
             12.2.10 NOVACHEM 
             12.2.11 ALFA CHEMISTRY
             12.2.12 LABSERT 
13 APPENDIX 
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 AVAILABLE CUSTOMIZATIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS